Skip to Content

Avecho Biotechnology Ltd AVEFF Stock Quote

| Rating as of


Last close prices updated as of Jan 19, 2023, 10:19 AM EST | USD
  • Last Close 0.021
  • Sector Healthcare
  • Industry Biotechnology
  • Investment Style Small Growth
  • Day Range 0.02  –  0.02
  • Year Range < 0.01  –  0.02
  • Market Cap 38.5953 Mil
  • Volume / Avg 20,000.0 /  730,186.0
  • Price / Sales 42.40
  • Price / Book 14.06
  • Forward Div Yield
  • Trailing Div Yield

Morningstar‘s Stock Analysis AVEFF

Currency in
Is it the right time to buy or sell?
Is it the right time to buy or sell?

1-Star Price


5-Star Price


Economic Moat


About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Unlock Our Full Analysis With Morningstar Investor

Key Statistics AVEFF

Company Profile AVEFF

Business Description

Avecho Biotechnology Ltd is a research-based biotechnology company engaged in the development, production, sale, and licensing of products incorporating its patented platform technology TPM, for the pharmaceutical, skincare and animal health and nutrition industries. Its segments include Production, Human Health, and other segments. The Production segment, which is the key revenue driver, manufactures and sells TPM and Vital ET for use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers the delivery of drugs through gels, injectables, and patches. It focuses on the development of patches, including TPM/Oxymorphone and TPM/Oxycodone.

Unit A8, 2A Westall Road, Clayton
Melbourne, VIC, 3168, AUS
Industry Biotechnology
Employees 34

FAQs for Avecho Biotechnology Ltd Stock

No. AVEFF does not currently have a forward dividend yield.
Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price.

Learn more about dividend yield.

AVEFF’s market cap is 38.60 Mil.
Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares. It’s often used to measure a company’s size. In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies.

Learn more about market capitalization.

AVEFF’s stock style is Small Growth.
Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

High-growth stocks tend to represent the technology, healthcare, and communications sectors. They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends.

Learn more about style.

AVEFF’s beta can be found in Trading Information at the top of this page.
A stock’s beta measures how closely tied its price movements have been to the performance of the overall market.

Compare AVEFF’s historical performance against its industry peers and the overall market.